期刊文献+

舒芬太尼预先给药对大鼠急性局灶性脑缺血-再灌注损伤的保护作用 被引量:11

Sufentanil pre-dosage induces protection against acute focal cerebral ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的观察舒芬太尼预先给药对大鼠大脑中动脉栓塞(MCAO)所致局灶性脑缺血-再灌注损伤的保护作用。方法40只雄性大鼠随机均分为四组,分别于缺血造模前腹腔注射舒芬太尼3μg/kg(S1组)、6μg/kg(S2组)、9μg/kg(S3组)和等容积生理盐水为对照组(C组)。给药后30 min,所有动物用右侧颈内动脉尼龙线线栓法致MCAO,120 min后恢复再灌注。再灌注24 h后记录神经功能障碍评分(NDS)。随后取大脑切片行TTC染色,计算脑梗死容积百分比。结果再灌注后24h,S1组NDS评分明显高于其他三组(P<0.05),梗死容积百分比明显低于其他三组(P<0.05),S2、S3、C组间NDS评分和梗死容积百分比差异均无统计学意义。结论舒芬太尼3μg/kg预先给药可明显减轻大鼠局灶性脑缺血-再灌注损伤。 Objective To investigate whether sufentanil pre-dosage induces protection aganist acute focal cerebral ischemia-reperfusion injury in rats. Methods Forty male SD rats were randomly divided into four groups with 10 rats each. Before establishing animal model, the rats were intraperitoneally injected sufentanil 3 μg/kg(group S1 ),6μg/kg(group 82 ), 9 μg/kg(group S2 )or normal saline(group C). At 30 min after injection, all rats subjected to the right middle cerebral artery oeclusion(MCAO) for 120 min,which was followed by reperfusion. The neurological deficit scores(NDS)were evaluated at 24 h after reperfusion. Infarct volume, as a percentage of volume at normal cerebral hemisphere, was determined by TTC staining. Results At 24 h after reperfusion, the NDS was higher and infarct volume was less in group 81 than those in groups of 82 ,Sa and C(P〈0. 05). There were no significant differences in NDS and infarct volume among groups of S2, S3 and C. Conclusion Sufentanil preconditioning can protect rat brain against ischemiareperfusion injury.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2009年第11期978-979,共2页 Journal of Clinical Anesthesiology
基金 国家杰出青年科学基金(30725039) 国家自然科学基金(30600840 30772074)
关键词 舒芬太尼 脑缺血-再灌注损伤 Sufentanil Cerebral ischemia-reperfusion injury
  • 相关文献

参考文献4

二级参考文献29

  • 1赵高峰,张兴安,施冲,吴群林,徐波.靶控输注异丙酚复合瑞芬太尼或芬太尼全静脉麻醉[J].广东医学,2004,25(7):765-767. 被引量:103
  • 2史春霞,李立环,卿恩明,姜贞,李士通,姚尚龙,郭曲练,王文贤,熊利泽,张铁铮,齐娟,付志俭.舒芬太尼麻醉用于心血管手术的多中心临床研究[J].临床麻醉学杂志,2005,21(8):519-521. 被引量:114
  • 3苗晓茹,熊利泽,王强,雷翀.雷米芬太尼预处理对大鼠局灶性脑缺血-再灌注损伤的保护作用[J].临床麻醉学杂志,2006,22(4):277-279. 被引量:14
  • 4Ahonen J, Olkkola KT, Hynynen M, et al. Comparison of alfentanil, fentanyl and sufentanil for total intravenous anesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth, 2000,85: 533-540.
  • 5Murkin JM. Sufentanil anesthesia for major surgery: the muiticentre Canadian clinical trial . Can J Anaesth, 1989,36 : 343-349.
  • 6Mouren S, De Winter G, Guerrero SP, et al. The continuous recording of blood pressure in patients undergoing carotid surgery under remifentanil versus sufentanil analgesia. Anesth Analg, 2001,93: 1402-1409.
  • 7Lecomte P,Ouattara A,Le Manach Y, et al. The coronary and myocardial effects of remifentanil and sufentanil in the erythrocyte-perfused isolated rabbit heart. Anesth Analg, 2006,103: 9-14.
  • 8Xue FS,Liu KP,Liu Y,et al. Assessment of small-dose fentanyl and sufentanil blunting the cardiovascular responses to laryngoscopy and intubation in children. Paediatr Anaesth, 2007,17:568-574.
  • 9Lipton P. Ischemic cell death in brain neurons. Physiol Rev,1999, 79:1431-1568.
  • 10Kataoka K, Yanase H. Mild hypothermia-a revived countermeasure against ischemic neuronal damages. Neurosci Res,1998,32:103-117.

共引文献95

同被引文献105

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部